WoS Publication RDF
pages:- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- more...
- Effects of Single-Capsule 17 beta-Estradiol/Progesterone (TX-001HR) on Weight and Blood Pressure in Menopausal Women of the REPLENISH Trial Meeting Abstract
- Effects of social isolation and galactic cosmic radiation on fine motor skills and behavioral performance Article
- Effects of State Cigarette Excise Taxes and Smoke-Free Air Policies on State Per Capita Alcohol Consumption in the United States, 1980 to 2009 Article
- EFFECTS OF STRESSOR CONTROLLABILITY ON NEURAL PLASTICITY ASSOCIATED MRNA LEVELS IN MOUSE AMYGDALA AND MEDIAL PREFRONTAL CORTEX (MPFC) Meeting Abstract
- Effects of stressor controllability on transcriptional levels of c-fos, Arc, and brain-derived neurotrophic factor in mouse amygdala and medial prefrontal cortex Article
- EFFECTS OF STRESSOR PREDICTABILITY AND CONTROLLABILITY ON SLEEP IN MICE Meeting Abstract
- Effects of Stressor Predictability and Controllability on Sleep, Temperature, and Fear Behavior in Mice Article
- EFFECTS OF STRESSOR PREDICTABILITY ON ESCAPE LEARNING AND SLEEP IN MICE Meeting Abstract
- Effects of Stressor Predictability on Escape Learning and Sleep in Mice Article
- Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Article
- Effects of surrogate parenting on grandparents' well-being Article
- Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity Article
- Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity Meeting Abstract
- Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-at mRNA in Ishikawa cells implication for tibolone's effects on the endometrium Article
- Effects of transducer frequency and output power on the ultrasonographic contrast produced by Optison using fundamental and harmonic imaging techniques. Article
- Effects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms Meeting Abstract
- Effects of Virginia's booster seat law on children's restraint use Article
- Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism Article
- Effects of Well-Controlled HIV Infection on Complement Activation and Function Article
- Efficacy and acceptability of psychotherapeutic and pharmacological interventions for trauma-related nightmares: A systematic review and network meta-analysis Review
- Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug Article
- Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 mu g (Loestrin (R) 24 Fe) Article
- Efficacy and safety of an alternative onabotulinumtoxinA injection paradigm for refractory overactive bladder Article
- Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men Article
- Efficacy and Safety of Antioxidant Treatment With alpha-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy The NATHAN 1 trial Article
- Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial Article
- Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial Letter
- Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study.
- Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study Letter
- Efficacy and safety of benralizumab for the treatment of chronic rhinosinusitis with nasal polyps: results from the phase III OSTRO trial Meeting Abstract